Prognostic and Predictive Roles of MGMT Protein Expression and Promoter Methylation in Sporadic Pancreatic Neuroendocrine Neoplasms

Publisher： Karger

E-ISSN： 1423-0194|100|1|35-44

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.100, Iss.1, 2014-07, pp. : 35-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Relevance of Aberrant DNA Methylation in G1 and G2 Pancreatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 100, Iss. 1, 2014-07 ,pp. : 26-34

Karger

Access to resources Recommend Favorite

Immunohistochemical Expression and Prognostic Value of ER, PR and HER2/neu in Pancreatic and Small Intestinal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 93, Iss. 4, 2011-04 ,pp. : 249-258

Karger

Access to resources Recommend Favorite

Prognostic Factors and Long-Term Outcome of Pancreatic Neuroendocrine Neoplasms: Ki-67 Index Shows a Greater Impact on Survival than Disease Stage. The Large Experience of the Spanish National Tumor Registry (RGETNE)

By  

Neuroendocrinology, Vol. 98, Iss. 2, 2013-09 ,pp. : 156-168

Karger

Access to resources Recommend Favorite

Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2015-12 ,pp. : 758-770

Karger

Access to resources Recommend Favorite

Efficacy and Cost-Effectiveness of Immediate Surgery versus a Wait-and-See Strategy for Sporadic Nonfunctioning T1 Pancreatic Endocrine Neoplasms

By  

Neuroendocrinology, Vol. 101, Iss. 1, 2014-09 ,pp. : 25-34

Karger

Access to resources Recommend Favorite